This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.
Rxsight with Proprietary UV Adjustable Eye Lenses Filed Prospectu with SEC
Filed February 8, 2023 Full text at: https://tinyurl.com/24n2ccyc Excerpt: Company Overview We are a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. Our proprietary RxSight® Light Adjustable Lens system (“RxSight system”) is the first and only commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system is comprised of our RxSight Light Adjustable Lens® (“LAL®”), RxSight Light Delivery Device (“LDD™”) and accessories. Our LAL is a premium intraocular lens (“IOL”) made of proprietary photosensitive material that changes shape in response to specific patterns of…
Published in Legal
More from LegalMore posts in Legal »
- John K. Roberts at L3Harris Explains to Judge Albright Why Walmart Infringes on Solid-State Light Source Technology Designed by Bridgelux
- Drs. Michael Lebby & Brian D’Andrade Explain to Judge Gilliland Current Lighting Isn’t Infringing on Jiaxing & Obert’s Lighting Technology Patents
- Duplo Turns to Drs. Charles F. Reinholtz & Chris E. Scott to Explain How It Doesn’t Infringe on MGI Digital’s Ultraviolet Printing Technology Patents
- Samsung & Seoul Semi Call Validity of LED Wafer’s Lighting Technology Patents into Question
- Hilco Says Recently Unsealed <i>Qui Tam</i> Claims Included in LiteSheet Asset Sale